Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke (PHAST-TSC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03763929

Recruitment Status : Terminated (The study was stopped due to lack of meaningful enrollment due to the COVID-19 pandemic.)

First Posted : December 4, 2018

Last Update Posted : December 17, 2020

Sponsor:

Collaborators:

University of California, Los Angeles

University of Virginia

Information provided by (Responsible Party):

Diffusion Pharmaceuticals Inc

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	October 19, 2020
Actual Study Completion Date :	October 19, 2020

To Top